SARS-COV-2 infection presenting as ST-elevationmyocardial infarction.
Francesco Castagna1, Roberto Cerrud-Rodriguez1, Miguel Alvarez Villela1
1Department of Medicine, Division of Cardiology, Montefiore Health System, Albert Einstein College of Medicine, New York, New York, USA.
A patient experienced acute cardiogenic shock due to SARS-CoV-2 infection, presenting with chest discomfort and ST elevation. Early diagnosis was challenging due to initial negative tests and emergent circumstances.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can manifest with diverse clinical presentations.
- Cardiac complications, including acute cardiogenic shock, are recognized but less common manifestations of SARS-CoV-2.
Observation:
- A patient presented with chest discomfort and anterolateral ST elevation, rapidly progressing to acute cardiogenic shock.
- The patient was identified as a potential "patient zero" upon arrival at the cardiac catheterization laboratory.
- Initial diagnostic workup for SARS-CoV-2 yielded two negative results, complicating the diagnostic process.
Findings:
- Despite initial negative tests, high clinical suspicion based on occupational history prompted further investigation.
- The patient was ultimately diagnosed with SARS-CoV-2 infection, confirmed through additional testing.
- The case highlights the potential for SARS-CoV-2 to cause severe cardiac events.
Implications:
- This case underscores the importance of considering SARS-CoV-2 infection in patients with acute cardiac syndromes, even with initial negative testing.
- Healthcare providers must maintain a high index of suspicion for infectious etiologies in emergent cardiac presentations.
- The case emphasizes the need for robust infection control protocols in cardiac catheterization laboratories when managing potentially infectious patients.
More Related Videos
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
